E
ExpreS2ion Biotech Holding AB
STO:EXPRS2
ExpreS2ion Biotech Holding AB
STO:EXPRS2
Price:
6.59
SEK
2.81%
Market Cap:
kr23.3m
Wall Street
Price Targets
EXPRS2 Price Targets Summary
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB
Wall Street analysts forecast EXPRS2 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 76.5 SEK with a low forecast of 75.75 SEK and a high forecast of 78.75 SEK.
Lowest
Price Target
75.75
SEK
1 049% Upside
Average
Price Target
76.5
SEK
1 061% Upside
Highest
Price Target
78.75
SEK
1 095% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EXPRS2's stock price target?
Price Target
76.5
SEK
76.5
SEK
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 76.5 SEK with a low forecast of 75.75 SEK and a high forecast of 78.75 SEK.
What is ExpreS2ion Biotech Holding AB's Revenue forecast?
Projected CAGR
360%
360%
The compound annual growth rate of ExpreS2ion Biotech Holding AB's revenue for the next 2 years is 360%.
